Preventing Cytomegalovirus Infection in High-Risk Bone Marrow Transplant Patients

Download All
In this CCO program that includes an Interactive Virtual Presentation, 2 ClinicalThought commentaries, and a downloadable slideset, expert faculty discuss best practices and recent clinical data surrounding the prevention and treatment of CMV infection in patients undergoing bone marrow transplantation.
Roy F. Chemaly, MD
Genovefa A. Papanicolaou, MD

ClinicalThought

How might emerging investigational agents change the management of CMV infection in the post–hematopoietic cell transplantation setting? Here’s my take.

Roy F. Chemaly, MD Released: September 6, 2017

How has the approval of letermovir prophylaxis altered post-HCT CMV management? Here’s my take.

Genovefa A. Papanicolaou, MD Released: January 16, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings